HEADER MEMBRANE PROTEIN 17-JUN-22 8DDD TITLE INTRAMEMBRANE RECOGNITION BETWEEN TRANSMEMBRANE DOMAINS OF IL-9R AND TITLE 2 COMMON GAMMA CHAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOKINE RECEPTOR COMMON SUBUNIT GAMMA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: TRANSMEMBRANE DOMAIN, RESIDUES 253-286; COMPND 5 SYNONYM: INTERLEUKIN-2 RECEPTOR SUBUNIT GAMMA,IL-2 RECEPTOR SUBUNIT COMPND 6 GAMMA,IL-2R SUBUNIT GAMMA,IL-2RG,GAMMAC,P64; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: INTERLEUKIN-9 RECEPTOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: TRANSMEMBRANE DOMAIN, RESIDUES 268-298; COMPND 13 SYNONYM: IL-9 RECEPTOR,IL-9R; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: IL2RG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 GENE: IL9R; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VARIANT: C43 KEYWDS COMMON GAMMA-CHAIN CYTOKINE RECEPTOR, TRANSMEMBRANE DOMAIN, RECEPTOR KEYWDS 2 SHARING, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR R.LENOIR CAPELLO,T.CAI,J.J.CHOU REVDAT 2 30-AUG-23 8DDD 1 JRNL REVDAT 1 05-JUL-23 8DDD 0 JRNL AUTH T.CAI,R.LENOIR CAPELLO,X.PI,H.WU,J.J.CHOU JRNL TITL STRUCTURAL BASIS OF GAMMA CHAIN FAMILY RECEPTOR SHARING AT JRNL TITL 2 THE MEMBRANE LEVEL. JRNL REF SCIENCE V. 381 569 2023 JRNL REFN ESSN 1095-9203 JRNL PMID 37535730 JRNL DOI 10.1126/SCIENCE.ADD1219 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DDD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000266437. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.7 REMARK 210 IONIC STRENGTH : 0.15 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.4 MM 15N, 13C, 85%2H REMARK 210 TRANSMEMBRANE DOMAIN OF THE REMARK 210 COMMON GAMMA-CHAIN RECEPTOR, 40 REMARK 210 MM DMPC, 100 MM DH6PC, 90% H2O/ REMARK 210 10% D2O; 0.4 MM 15N, 13C, 85%2H REMARK 210 TRANSMEMBRANE DOMAIN OF THE REMARK 210 INTERLEUKIN-9 RECEPTOR ALPHA REMARK 210 SUBUNIT, 40 MM DMPC, 100 MM REMARK 210 DH6PC, 90% H2O/10% D2O; 0.4 MM REMARK 210 13C TRANSMEMBRANE DOMAIN OF THE REMARK 210 INTERLEUKIN-9 RECEPTOR ALPHA REMARK 210 SUBUNIT, 0.4 MM 15N, 2H REMARK 210 TRANSMEMBRANE DOMAIN OF THE REMARK 210 COMMON GAMMA-CHAIN RECEPTOR, 80 REMARK 210 MM DEUTERATED DMPC, 200 MM REMARK 210 DEUTERATED DH6PC, 90% H2O/10% REMARK 210 D2O; 0.4 MM 13C TRANSMEMBRANE REMARK 210 DOMAIN OF THE COMMON GAMMA-CHAIN REMARK 210 RECEPTOR, 0.4 MM 15N, 2H REMARK 210 TRANSMEMBRANE DOMAIN OF THE REMARK 210 INTERLEUKIN-9 RECEPTOR ALPHA REMARK 210 SUBUNIT, 80 MM DEUTERATED DMPC, REMARK 210 200 MM DEUTERATED DH6PC, 90% H2O/ REMARK 210 10% D2O; 0.4 MM 13C REMARK 210 TRANSMEMBRANE DOMAIN OF THE REMARK 210 INTERLEUKIN-9 RECEPTOR ALPHA REMARK 210 SUBUNIT, 0.4 MM 15N, 2H REMARK 210 TRANSMEMBRANE DOMAIN OF THE REMARK 210 COMMON GAMMA-CHAIN RECEPTOR, 80 REMARK 210 MM DEUTERATED DMPC, 200 MM REMARK 210 DEUTERATED DH6PC, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N TROSY-HSQC; 2D 1H-13C REMARK 210 HSQC; 3D TROSY HNCA; 3D TROSY REMARK 210 HN(CO)CA; 3D TROSY HNCO; 3D REMARK 210 TROSY HNCACO; 3D 1H-15N NOESY- REMARK 210 TROSY; 3D 1H-13C NOESY; 2D REMARK 210 METHYL-AMIDE INTERMOLECULAR NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 700 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III; AVANCE NEO REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, XEASY, TALOS+ REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 255 156.63 60.04 REMARK 500 2 LEU A 261 151.15 -44.24 REMARK 500 2 TRP B 269 99.86 53.81 REMARK 500 2 SER B 270 64.40 -111.72 REMARK 500 3 GLU A 254 174.97 55.05 REMARK 500 3 ASN A 255 70.89 54.12 REMARK 500 3 LEU A 261 -175.02 -57.89 REMARK 500 4 ASN A 255 -58.09 -174.77 REMARK 500 4 SER B 270 83.47 -151.07 REMARK 500 5 ALA A 260 31.93 -89.55 REMARK 500 5 LEU A 261 -176.51 -62.25 REMARK 500 5 GLU A 285 -76.43 65.18 REMARK 500 6 ASN A 255 89.07 53.63 REMARK 500 6 ALA A 260 31.91 -93.28 REMARK 500 6 SER B 294 94.79 -162.04 REMARK 500 7 GLU A 254 -38.30 -142.49 REMARK 500 7 PRO A 256 33.12 -91.40 REMARK 500 7 ALA A 260 35.89 -91.74 REMARK 500 7 LEU A 261 151.32 -43.35 REMARK 500 7 GLU A 285 148.92 61.97 REMARK 500 8 GLU A 254 73.48 55.41 REMARK 500 8 ASN A 255 117.51 -169.08 REMARK 500 8 ALA A 260 43.39 -88.04 REMARK 500 8 PRO B 295 32.23 -91.50 REMARK 500 9 LEU A 261 106.82 38.56 REMARK 500 9 TRP B 269 94.33 58.68 REMARK 500 9 SER B 270 47.85 -87.93 REMARK 500 9 PRO B 295 34.16 -89.39 REMARK 500 10 GLU A 285 174.38 59.53 REMARK 500 10 TRP B 269 175.74 55.68 REMARK 500 11 ALA A 260 31.25 -90.73 REMARK 500 11 SER B 270 -32.84 -172.40 REMARK 500 12 ASN A 255 90.19 -176.11 REMARK 500 12 ALA A 260 33.12 -89.65 REMARK 500 12 LEU A 261 -173.68 -58.25 REMARK 500 13 PRO A 256 69.60 -68.83 REMARK 500 13 LEU A 261 -179.04 -61.81 REMARK 500 13 GLU A 285 153.20 60.69 REMARK 500 14 PRO A 256 38.48 -87.89 REMARK 500 14 SER B 270 104.79 -53.71 REMARK 500 15 PRO A 256 36.52 -84.56 REMARK 500 15 ALA A 260 39.57 -91.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 31027 RELATED DB: BMRB REMARK 900 INTRAMEMBRANE RECOGNITION BETWEEN TRANSMEMBRANE DOMAINS OF IL-9R REMARK 900 AND COMMON GAMMA CHAIN DBREF 8DDD A 253 286 UNP P34902 IL2RG_MOUSE 253 286 DBREF 8DDD B 268 298 UNP Q01114 IL9R_MOUSE 268 298 SEQADV 8DDD VAL A 271 UNP P34902 MET 271 ENGINEERED MUTATION SEQADV 8DDD PHE A 282 UNP P34902 CYS 282 ENGINEERED MUTATION SEQRES 1 A 34 GLU GLU ASN PRO SER LEU PHE ALA LEU GLU ALA VAL LEU SEQRES 2 A 34 ILE PRO VAL GLY THR VAL GLY LEU ILE ILE THR LEU ILE SEQRES 3 A 34 PHE VAL TYR PHE TRP LEU GLU ARG SEQRES 1 B 31 GLN TRP SER ALA SER ILE LEU VAL VAL VAL PRO ILE PHE SEQRES 2 B 31 LEU LEU LEU THR GLY PHE VAL HIS LEU LEU PHE LYS LEU SEQRES 3 B 31 SER PRO ARG LEU LYS HELIX 1 AA1 PRO A 256 ALA A 260 5 5 HELIX 2 AA2 LEU A 261 GLU A 285 1 25 HELIX 3 AA3 SER B 270 LEU B 293 1 24 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1